Venture Life Group PLC (LON:VLG) insider Carl Dempsey acquired 20,000 shares of the stock in a transaction dated Thursday, July 11th. The shares were bought at an average cost of GBX 51 ($0.67) per share, for a total transaction of £10,200 ($13,328.11).

Shares of LON VLG opened at GBX 51.50 ($0.67) on Friday. The company has a debt-to-equity ratio of 22.03, a quick ratio of 2.43 and a current ratio of 3.03. The firm has a market cap of $43.11 million and a price-to-earnings ratio of 128.75. The firm’s 50-day moving average is GBX 46.18. Venture Life Group PLC has a 52 week low of GBX 36.75 ($0.48) and a 52 week high of GBX 55 ($0.72).

Venture Life Group Company Profile

Venture Life Group Plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain.

Featured Article: What is the downside to momentum investing?

Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.